Vicarious Surgical (RBOT) Income from Non-Controlling Interests (2020 - 2021)
Vicarious Surgical (RBOT) posted quarterly Income from Non-Controlling Interests of -$21.0 million for Q2 2021, down 78652.22% year-over-year from N/an in Q2 2020, and down 78652.22% quarter-over-quarter from -$26704.0 in Q2 2020.
Vicarious Surgical (RBOT) Income from Non-Controlling Interests (2020 - 2021) Analysis & Trends
Vicarious Surgical (RBOT) has reported Income from Non-Controlling Interests for 2 consecutive years, with -$21.0 million the latest figure, recorded in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 900,000.00 |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -21.03 Mn |
| Jun 30, 2020 | -26,704.00 |